CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
2022 · Proceedings of the National Academy of Sciences · 186 citations
https://doi.org/10.1073/pnas.2114282119
T
Taigo Kato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
317
Papers
3.2K
Citations
33
h-index
70
i10-index
Taigo Kato is an academic researcher from Osaka Gakuin University. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Immunotherapy and Biomarkers & Bladder and Urothelial Cancer Treatments. The author has an h-index of 33, co-authored 270 publications.
ORCID: 0000-0002-8681-1407Papers by this author
worksExpression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
2020 · International Journal of Molecular Sciences · 104 citations
https://doi.org/10.3390/ijms21155390
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients
2022 · Cancer Immunology Immunotherapy · 14 citations
https://doi.org/10.1007/s00262-022-03213-5
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
2023 · Heliyon · 13 citations
https://doi.org/10.1016/j.heliyon.2023.e19800
Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
2022 · Advances in Radiation Oncology · 10 citations
https://doi.org/10.1016/j.adro.2022.101157
Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project
2024 · BJC Reports · 9 citations
https://doi.org/10.1038/s44276-024-00049-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat